Methods and compositions to support tissue integration and inosculation of transplanted tissue and transplanted engineered penile tissue with adipose stromal cells
The present invention generally relates to methods, compositions and uses thereof for enhancing vascularization of a tissue or cell transplant for transplantation into a subject. In particular, one aspect of the present invention provides methods and compositions comprising the use of a population of stromal vascular fraction (SVF) cells to encapsulate or surround a tissue or cell transplant to enhance vascularization of the tissue or cell transplant. Another aspect of the present invention provides methods and compositions for enhancing vascularization of a tissue or cell transplant by combining a population of SVF cells with a tissue or cell transplant to form a transplant mixed with SVF cells. Another aspect provides a composition comprising an engineered corpus cavernosum tissue comprising SVF cells and corpus cavernosum cells, wherein the SVF cells can be mixed with or encasing the corpus cavernosum cells, and methods of uses thereof, for example in method for the treatment of impotence and erectile dysfunction and/or enhance or construct a penis. In some embodiments, the SVF cells can be generically engineered to secrete therapeutic proteins or pro-angiogenic factors.
1. A method for enhancing the function of the penis of a subject in need thereof comprising: providing an engineered corpus cavernosum cell transplant, wherein said cell transplant comprises a substantially pure population of freshly isolated stromal vascular fraction (SVF) cells present in a biocompatible liquid three-dimensional matrix, and injecting the engineered corpus cavernosum cell transplant into the penis of a subject.
2. The method of claim 1 , wherein the engineered corpus cavernosum cell transplant is injected into the corpus cavernosa of the subject.
3. The method of claim 1 , wherein the subject has been diagnosed with, or is at risk of developing erectile dysfunction.
4. The method of claim 1 , wherein the subject has impotence.
5. The method of claim 4 , wherein the impotence is organic impotence.
6. The method of claim 5 , wherein the organic impotence is due to endocrinologic or metabolic disease.
7. The method of claim 1 , wherein the subject is human.
8. The method of claim 1 , wherein the cell transplant further comprises at least one additional cell type or population of relevant cells, wherein the relevant cells includes a population of corpus cavernosa cells or microvessel fragments.
9. The method of claim 1 , wherein the cell transplant does not comprise endothelial cells.
10. The method of claim 1 , wherein the substantially pure population of SVF cells are autologous SVF cells.
11. The method of claim 1 , wherein the biocompatible liquid three dimensional matrix polymerizes or substantially polymerizes in situ after injection into the penis of the subject.
12. The method of claim 1 , wherein the freshly isolated stromal vascular fraction (SVF) cells are injected into penis of the subject within about 1 hour or less after being harvested from the subject.
13. A method to improve penile erectile function in a subject comprising injecting into the corpus cavernosum of the penis of the subject a composition comprising a substantially pure population of freshly isolated stromal vascular fraction (SVF) cells present in a biocompatible liquid three-dimensional matrix.
14. The method of claim 13 , wherein the SVF cells are present on the surface, or embedded within the biocompatible liquid three-dimensional matrix.
15. The method of claim 13 , wherein the subject is a human subject.
16. The method of claim 13 , wherein the composition comprises at least one additional cell type or population of relevant cells, selected from any in the group consisting of: corpus cavernosa cells, microvessel fragments.
17. The method of claim 13 , wherein the composition does not comprise endothelial cells.
18. The method of claim 13 , wherein the SVF cells are autologous SVF cells.
19. The method of claim 13 , wherein the subject has been diagnosed with, or is at risk of developing erectile dysfunction.
20. The method of claim 19 , wherein the erectile dysfunction is impotence.
21. The method of claim 20 , wherein the impotence is organic impotence.
22. The method of claim 21 , wherein the organic impotence is due to endocrinologic or metabolic disease.
23. The method of claim 13 , wherein the biocompatible liquid three dimensional matrix polymerizes or substantially polymerizes in situ after injection into the corpus cavernosum of the penis of the subject.
24. The method of claim 13 , wherein the freshly isolated stromal vascular fraction (SVF) cells are injected into penis of the subject within about 1 hour or less after being harvested from the subject.
25. A method for treating erectile dysfunction in a subject comprising injecting into the corpus cavernosum of the penis of the subject a composition comprising a substantially pure population of freshly isolated stromal vascular fraction (SVF) cells present in a biocompatible liquid three-dimensional matrix.
26. The method of claim 25 , wherein the biocompatible liquid three dimensional matrix polymerizes or substantially polymerizes in situ after injection into the corpus cavernosum of the penis of the subject.
27. The method of claim 25 , wherein the freshly isolated stromal vascular fraction (SVF) cells are injected into penis of the subject within about 1 hour or less after being harvested from the subject.